0001225208-23-002532.txt : 20230222
0001225208-23-002532.hdr.sgml : 20230222
20230222165544
ACCESSION NUMBER: 0001225208-23-002532
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230221
FILED AS OF DATE: 20230222
DATE AS OF CHANGE: 20230222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mirviss Jeffrey B.
CENTRAL INDEX KEY: 0001566094
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 23654213
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2023-02-21
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001566094
Mirviss Jeffrey B.
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP&Pres, Periph Intervent
Common Stock
2023-02-21
4
M
0
2804.0000
0.0000
A
95411.0000
D
Common Stock
2023-02-21
4
F
0
1279.0000
46.2300
D
94132.0000
D
Common Stock
2023-02-21
4
S
0
2313.0000
46.3200
D
91819.0000
D
Common Stock
2023-02-22
4
S
0
3340.0000
46.1000
D
88479.0000
D
Deferred Stock Units
2023-02-21
4
M
0
2804.0000
0.0000
D
2023-02-21
Common Stock
2804.0000
0.0000
D
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
/s/ Susan Thompson, Attorney-in-Fact
2023-02-22